Home / Drugs / Medicago sativa

Medicago sativa

FDA Drug Profile — Alfalfa, Alfalfa Pollen

Drug Details

Generic Name
Medicago sativa
Brand Names
Alfalfa, Alfalfa Pollen
Application Number
BLA101833
Sponsor
Greer Laboratories, Inc.
NDC Codes
6
Dosage Forms
SOLUTION, INJECTION
Routes
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS, CUTANEOUS
Active Ingredients
MEDICAGO SATIVA POLLEN

Indications and Usage

Long-term administration of the product:1、Auxiliary effect on improving sexual desire and strengtheningprostate problems; 2、Auxiliary effect on kidney stones and bladder stones;

Warnings

For your health, please read the followingcarefully 1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product; 5. This product certainly has significant effect on gout,crystallization and hyperuricemia;